Transcatheter treatment of torrential tricuspid regurgitation using a novel spacer device

31 August 2026 (08:59 - 09:15)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Andrew Moussad

Nepean Hospital, Sydney (Australia)

4 More presentations in this session

Presentation thumbnail

Clinical cases of guideline-direct therapy for tricuspid and mitral valve disease - get ready for the session

Doctor A. Sorropago (Monza, IT)

Presentation thumbnail

Multimodality Treatment of HFrEF: From Device Therapy to M-TEER

Doctor R. Salim (Bucharest, RO)

Presentation thumbnail

Left ventricular outflow tract obstruction after mechanical mitral valve replacement caused by anterior papillary muscle interposition

Doctor A. Chikovani (Tbilisi, GE)

Presentation thumbnail

Unexplained hypoxemia in carcinoid heart disease: when TR takes an unexpected direction

Doctor R. Wimolwattanaphan (Bangkok, TH)

Access the full session

Session thumbnail

Clinical cases of guideline-directed therapy for tricuspid and mitral valve disease

The Event

Event poster

ESC Congress 2026

31 August 2026 08:59 CET

You may be interested in

Congress Presentation

Rescue TTVR with a new-sized EVOQUE valve following transcatheter edge-to-edge repair

21 March 2026

Congress Presentation

Transcatheter edge-to-edge repair of severe tricuspid regurgitation with the pascal system. one-year results of a pioneering series in spain, with the use of the pascal system.

12 December 2024

Congress Presentation

Predictors of haemodynamic response to transcatheter tricuspid valve replacement for severe tricuspid regurgitation

1 September 2025

Congress Session

Facts and perspectives in secondary tricuspid regurgitation

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources